Incoming-goods inspection for research materials often begins and ends with a purity figure. A certificate may state a high percentage, the vial is logged in, and the shipment moves to storage. That workflow is understandable, but it leaves a gap. A purity percentage describes the proportion of a main component in a sample; it does not, on its own, confirm that the component is the compound named on the label. For laboratories working with research-use-only materials, identity testing must sit beside the purity percentage, not behind it. These materials are not for human or veterinary use, and they are not medicines, medical devices, injectables, treatments or food supplements under UK law. Incoming inspection should therefore treat identity and purity as two separate questions, each answered by the batch documentation and each recorded before release to the bench.
The Limit of a Purity Percentage in Incoming-Goods Inspection
A purity percentage is a quantitative summary. In the context of the HPLC documentation described by Research Sciences, it indicates the proportion of the main peak in the analysis. That is useful, but it is not an identity result. A sample can show a high purity percentage and still be the wrong material, a mislabelled analogue, a cross-contaminated preparation or a degradation product that elutes close to the expected compound. The percentage tells the reviewer how much of the main component is present; identity testing tells the reviewer what that component is. Without the identity check, a high purity figure can create false confidence.
The shop’s homepage currently lists “≥99% Verified Purity” and “3,000+ UK Orders”, and the FAQs describe peptides as typically supplied at ≥99% purity by HPLC, with the exact purity stated on the CoA. These are published lines at the time of writing and should be reconfirmed on the live site and, more importantly, on the batch CoA that accompanies the specific vial. A headline figure is not a substitute for the batch document. Incoming-goods inspection should open the CoA, locate the identity section, compare the stated material with the catalogue item and label reference, and then record both the identity result and the purity result. If either is missing or unclear, the batch should be held pending clarification.
The label reference is part of this check. Research Sciences describes a format that combines the SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. Quoting that reference when contacting the shop about documentation keeps the audit trail tidy. It also helps prevent a common error: filing a CoA from an earlier delivery against a later vial without confirming that the document belongs to the batch in hand. A purity percentage without a traceable identity check is an incomplete inspection record. Materials are not for human or veterinary use, and this documentation discipline is part of keeping research workflows within lawful laboratory use.
Identity Testing as a Gatekeeper for Research-Use-Only Materials
Identity testing acts as a gatekeeper because it answers a different question from purity. It confirms that the material matches the expected compound, rather than merely confirming that most of the sample is a single substance. For a materials manager, the practical test is simple: can the batch CoA be matched to the label, the catalogue listing and the internal goods-in record? If the identity section is absent, ambiguous or inconsistent with the label, the purity percentage should not override the discrepancy. The two metrics work together: identity establishes what the material is, and purity establishes how much of the main component is present.
The supplier’s testing framework matters here. Research Sciences describes full-spectrum testing that includes purity, identity, heavy metals and endotoxin evaluation of submitted samples, with CoAs linked to supported products. The homepage also lists “CoAs Janoshik Analytical Reports”, and researchers should open and check the CoA that accompanies the specific batch rather than relying on a general statement. For UK laboratories comparing documentation trails, the Uk peptides catalogue from Research Sciences is an example of a supplier that links supported products to batch-level certificates; the reviewer still needs to verify the identity section, the batch reference and the storage instructions on that certificate. These materials remain research-use-only and are not for human or veterinary use.
There is also a restock caveat. The FAQs state that restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. Incoming inspection should therefore rely on the batch CoA and label reference, not on packaging appearance. If the ITR is the only common reference between two deliveries, the reviewer should record that fact and seek confirmation where the identity of the current batch is not clearly documented.
A Practical Incoming-Goods Checklist for Purity and Identity
A workable checklist keeps identity and purity visible at the point of receipt. First, confirm the label reference and match it to the catalogue item. Second, open the batch CoA and check that the identity section corresponds to the labelled material. Third, check the purity section and note the stated value, recognising that the exact figure should come from the batch CoA rather than a homepage headline. Fourth, review any additional testing described for the batch, such as heavy metals and endotoxin screening, and record whether those results are present. Fifth, log the ITR and any batch-specific notes so that a later audit can trace the decision.
Handling records should sit alongside the analytical checks. Research Sciences describes temperature-aware storage and tracked UK dispatch, but the receiving laboratory still needs to confirm that the material arrived in suitable condition and that storage follows the label and CoA. The FAQ quick guide says vials should be allowed to reach room temperature before opening, work should take place in a clean environment, and only the amount required for the experiment should be removed. Lyophilised peptides should be stored at –20°C or below, sealed with desiccant, protected from moisture, heat and light, with repeated freeze–thaw cycles avoided. Reconstituted peptides are less stable and should be kept at 2–8°C for short-term laboratory use. All of this is in-vitro laboratory workflow only; the materials are not for human or veterinary use, and the reconstitution calculator is for laboratory research use only, not for dosing.
The inspection record should show both the identity result and the purity result, with the batch CoA as the anchor. When the vial is later used in an in-vitro experiment, that record allows the laboratory to trace the release decision back to the specific batch. Attach the CoA to the goods-in form, note the label reference and the ITR, and file the record with the storage log. This keeps the identity check and the purity percentage visible at the point of use, not just at the point of receipt.
A Sarajevo native now calling Copenhagen home, Luka has photographed civil-engineering megaprojects, reviewed indie horror games, and investigated Balkan folk medicine. Holder of a double master’s in Urban Planning and Linguistics, he collects subway tickets and speaks five Slavic languages—plus Danish for pastry ordering.